Shares of AngioDynamics, Inc. (NASDAQ:ANGO) are up Thursday after the biotechnology company raised guidance for four key financial metrics and shared positive sales performance for this past quarter.
What To Know: AngioDynamics’s stock jumped 11% after the company released its financial results from the first quarter of fiscal 2026. Shares of the company, which makes products for patients with cardiovascular and oncologic diseases, were trading just above $12 at last check, according to Benzinga Pro.
AngioDynamics reported first-quarter revenue of $75.71 million, beating estimates of $72.73 million, according to Benzinga Pro. The company reported a first-quarter loss of 10 cents per share, beating estimates for a loss …